26 ANAESTHETICS, SEDATION & ANALGESIA
# 27 ANAESTHETICS, SEDATION & ANALGESIA
π©ββοΈ Anaesthetics is predictable territory in MRCS Part A. Examiners return to the same cluster: LA dose calculations, the WHO ladder, ketamine in shock, opioid reversal, malignant hyperthermia, and suxamethonium contraindications. Recite the antidotes cold and calculate a lidocaine maximum in under thirty seconds β easy marks.
The three phases of general anaesthesia
GA rests on the triad: hypnosis + analgesia + muscle relaxation. No single drug delivers all three safely.
β‘ Induction β IV agent renders the patient unconscious in ~30 s (one arm-brain circulation).
β‘ Maintenance β volatile agent Β± nitrous oxide Β± opioid; alternatively TIVA with propofol infusion.
β‘ Emergence β agents stopped, neuromuscular block reversed, reflexes return.
π©ββοΈ Post-induction hypotension is the rule: all IV induction agents (except ketamine) venodilate, dropping preload. Propofol and thiopentone add direct myocardial depression.
IV induction agents
| Agent | Mechanism | Strengths | Watch out for |
|---|---|---|---|
| Propofol | GABA-A | Rapid on/off, antiemetic, smooth recovery | Hypotension, pain on injection, propofol infusion syndrome |
| Thiopentone | Barbiturate (GABA-A) | Rapid, anticonvulsant | Contraindicated in porphyria, hypotension, tissue necrosis if extravasated |
| Ketamine | NMDA antagonist | Maintains airway, raises BP/HR, bronchodilator, analgesic | Emergence delirium, raises ICP/IOP, secretions |
| Etomidate | GABA-A | Most cardiovascularly stable | Adrenal suppression (11Ξ²-hydroxylase) β single dose only |
π©ββοΈ Ketamine vs etomidate is a classic discrimination. Both suit the unstable patient: ketamine raises BP (sympathomimetic β trauma, shock, asthma); etomidate is BP-neutral (cardiac patients). Stem says "stable" β etomidate. Stem says "shock/trauma/pre-hospital" β ketamine.
Inhalational agents
- Sevoflurane β sweet, non-pungent β agent of choice for gas induction (paediatrics).
- Isoflurane β cheap, stable maintenance agent.
- Desflurane β lowest blood-gas solubility β fastest onset/offset. Pungent (no induction).
- Nitrous oxide β analgesic, MAC-sparing. Diffuses into air-filled spaces β avoid in pneumothorax, bowel obstruction, middle-ear surgery. Inhibits methionine synthase β megaloblastic anaemia with prolonged use.
All volatiles trigger malignant hyperthermia.
Muscle relaxants
Both classes act at the nicotinic ACh receptor of the motor endplate.
Depolarising β suxamethonium
The only depolariser in use. Mimics ACh β sustained depolarisation β fasciculations β flaccid paralysis. Metabolised by plasma cholinesterase: onset 30β60 s, duration 5β10 min. Drug of choice for rapid sequence intubation.
Side effects:
- Hyperkalaemia β dangerous in burns (>24 h), denervation, spinal cord injury, crush.
- Malignant hyperthermia trigger.
- Bradycardia (esp. second dose, paediatrics) β pretreat with atropine.
- Raised IOP and intragastric pressure.
- Suxamethonium apnoea β prolonged paralysis in pseudocholinesterase deficiency.
π©ββοΈ "Sux sucks potassium out of cells." Avoid in burns, crush, hyperkalaemia.
Non-depolarising β the "-curoniums"
Competitive nicotinic antagonists: rocuronium (fast onset β RSI alternative), vecuronium, atracurium (Hofmann elimination β safe in renal/hepatic failure), pancuronium. Reversed by:
- Neostigmine + glycopyrrolate β neostigmine raises synaptic ACh to outcompete the blocker; glycopyrrolate prevents muscarinic side effects.
- Sugammadex β cyclodextrin that encapsulates rocuronium/vecuronium; works at any depth of block.
Local anaesthetics
LAs are weak bases that block voltage-gated NaβΊ channels from the inner axon membrane, preventing depolarisation. Acidic environments (infected tissue) keep them ionised and impair penetration β hence the difficulty anaesthetising an abscess.
Amides vs esters
| Amides (two "i"s) | Esters (one "i") | |
|---|---|---|
| Examples | Lidocaine, bupivacaine, prilocaine, ropivacaine | Cocaine, procaine, tetracaine, benzocaine |
| Metabolism | Hepatic (CYP450) | Plasma cholinesterase |
| Allergy | Very rare | More common (PABA metabolite) |
Maximum doses (must memorise)
| Drug | Plain | With adrenaline |
|---|---|---|
| Lidocaine | 3 mg/kg | 7 mg/kg |
| Bupivacaine | 2 mg/kg | 2 mg/kg (adrenaline doesn't raise the max) |
| Prilocaine | 6 mg/kg | 9 mg/kg |
1% = 10 mg/mL. Worked example: 70 kg, 1% lidocaine + adrenaline β 70 Γ 7 = 490 mg β 49 mL max.
π©ββοΈ "Lidocaine 3 alone, 7 with adr-E-naline."
Why add adrenaline?
Vasoconstriction (1) reduces systemic absorption β raises max safe dose, (2) prolongs block, (3) provides haemostasis (scalp, face).
Never in end-artery territories: fingers, toes, nose, ears, penis. Never in Bier's block β catastrophic if the tourniquet fails.
LA toxicity
Progressive CNS then cardiac signs as plasma levels rise:
β‘ Perioral tingling, tinnitus, visual disturbance β seizures β coma β cardiovascular collapse.
π©ββοΈ "Lips Tingle, Ears Ring, Eyes Blur, Brain Seizes, Heart Stops."
Bupivacaine is the most cardiotoxic LA β "fast in, slow out" at NaβΊ channels β refractory arrhythmias. Severe toxicity β 20% Intralipid (lipid sink sequestering the lipophilic drug) plus ALS.
Prilocaine is the least toxic β agent of choice in Bier's block. Risk: methaemoglobinaemia (treat with methylene blue).
Spinal vs epidural anaesthesia
| Spinal | Epidural | |
|---|---|---|
| Space | Subarachnoid (CSF) | Epidural (outside dura) |
| Level | Below L2 | Any level |
| Onset | Rapid (5 min) | Slow (15β30 min) |
| Duration | Fixed (single shot) | Indefinite (catheter) |
| Use | C-section, TURP, lower limb | Labour analgesia, post-op |
Both risk hypotension (sympathetic block), urinary retention, total spinal and epidural haematoma (anticoagulated patients). Dural puncture β post-dural puncture headache (treat with fluids, caffeine, blood patch).
π©ββοΈ "Spinal = Single shot, Subarachnoid. Epidural = Extradural, cathEter."
Sedation tiers
Sedation is a continuum; the operator must be able to rescue from one level deeper.
| Tier | Response | Airway |
|---|---|---|
| Minimal (anxiolysis) | Normal to verbal | Unaffected |
| Moderate (conscious) | Purposeful to verbal/touch | Maintained |
| Deep | Only to painful stimulus | May need support |
| GA | Unrousable | Often needs intervention |
- Midazolam β benzodiazepine; conscious sedation for endoscopy. Reversed by flumazenil.
- Propofol β deep sedation; no reversal agent.
- Ketamine β preserves airway reflexes; useful for paediatric procedural sedation.
Analgesia β the WHO ladder
β‘ Step 1 β non-opioid (paracetamol, NSAIDs) Β± adjuvant.
β‘ Step 2 β weak opioid (codeine, tramadol) + non-opioid Β± adjuvant.
β‘ Step 3 β strong opioid (morphine, oxycodone, fentanyl) + non-opioid Β± adjuvant.
Adjuvants: gabapentin/amitriptyline (neuropathic); dexamethasone (cerebral oedema, nerve compression); bisphosphonates/radiotherapy (bone mets).
Opioids
All act at ΞΌ, ΞΊ, Ξ΄ opioid receptors β Gi-coupled GPCRs that hyperpolarise neurons. Morphine is a full ΞΌ agonist: brainstem ΞΌ receptors mediate analgesia, euphoria, respiratory depression, miosis, reduced GI motility.
- Morphine β gold standard; active metabolite M6G accumulates in renal failure.
- Fentanyl β 100Γ more potent, lipophilic, rapid onset; intra-op and transdermal.
- Oxycodone β preferred in renal impairment.
- Tramadol β weak ΞΌ agonist + SNRI activity. Lowers seizure threshold; serotonin syndrome with SSRIs.
Opioid toxicity triad: pinpoint pupils + respiratory depression + reduced GCS β naloxone (competitive ΞΌ antagonist). Short half-life (~30β60 min) β re-narcotisation; redose or infuse.
NSAIDs
Inhibit COX-1 and COX-2 β reduced prostaglandins. Side effects mirror lost physiological PGs:
- GI: ulceration, bleeding (PGEβ protects mucosa).
- Renal: AKI (PGs maintain afferent arteriolar dilatation).
- CV: hypertension, fluid retention, MI risk (COX-2).
- Bronchospasm in aspirin-sensitive asthma.
- Bleeding (platelet COX-1; aspirin irreversible).
Avoid in renal impairment, active GI bleeding, severe HF, and the triple whammy (NSAID + ACEi + diuretic).
Malignant hyperthermia
Autosomal dominant RyR1 mutation in skeletal muscle. Triggers β all volatiles and suxamethonium β cause uncontrolled CaΒ²βΊ release β sustained contraction β hypermetabolic crisis.
Presentation: rising end-tidal COβ (earliest), masseter spasm, tachycardia, rigidity, late hyperthermia, rhabdomyolysis, hyperkalaemia, acidosis.
Management: stop trigger, 100% Oβ, dantrolene 2.5 mg/kg IV (inhibits RyR1), cool, treat KβΊ and acidosis.
π©ββοΈ Antidote table β memorise cold:
| Effect | Antidote |
|---|---|
| Opioid | Naloxone |
| Benzodiazepine | Flumazenil |
| Non-depolarising block | Neostigmine + glycopyrrolate |
| Rocuronium/vecuronium | Sugammadex |
| LA toxicity | 20% Intralipid |
| Malignant hyperthermia | Dantrolene |
| Paracetamol | N-acetylcysteine |
| Heparin | Protamine |
| Warfarin | Vitamin K / PCC |
[Image: MCQs banner]
Test yourself
A patient develops hypotension immediately after induction of GA. What is the most likely mechanism?

- ((Decreased preload due to venodilation::βοΈ Almost all IV induction agents venodilate β the dominant mechanism.))
- ((Direct myocardial depression::Contributes (propofol/thiopentone) but secondary to venodilation.))
- ((Anaphylaxis::Possible but rare; expect rash and bronchospasm.))
- ((Increased vagal tone::Seen with airway instrumentation, not the main driver.))
- ((Tension pneumothorax::Needs trauma or PPV.))
π©ββοΈ Ketamine is the only IV induction agent that does not drop BP.
A lady suffers a Colles fracture. She has CKD and IHD. Which anaesthesia should be given?
- ((Bier's block (IV regional anaesthesia)::βοΈ Avoids GA β ideal forearm technique in cardiac/renal comorbidity.))
- ((General anaesthesia::Cardiovascular depression and altered drug clearance.))
- ((Axillary nerve block::Overkill for a distal radius reduction.))
- ((Haematoma block::Less reliable surgical anaesthesia.))
- ((Local infiltration only::Cannot reliably anaesthetise the fracture for manipulation.))
A 72-year-old female suffers a distal radial fracture. Which anaesthesia is most suitable for manipulation and reduction?
- ((Bier's block::βοΈ Avoids GA risk in elderly; bloodless field for short forearm work.))
- ((General anaesthesia::Higher cardiovascular and cognitive risk in this age group.))
- ((Haematoma block::Less reliable for manipulation.))
- ((Axillary brachial plexus block::Slower onset and technically demanding.))
- ((Sedation with morphine only::Inadequate for reduction.))
In a Bier's block, which local anaesthetic is most commonly used?
- ((0.5% Prilocaine::βοΈ Lowest systemic toxicity β the margin you need if the tourniquet fails.))
- ((0.5% Bupivacaine::Contraindicated β refractory cardiotoxicity on tourniquet failure.))
- ((2% Lidocaine::Higher toxicity than prilocaine.))
- ((0.75% Ropivacaine::Not standard in IVRA.))
- ((1% Lidocaine with adrenaline::Adrenaline is forbidden in Bier's block.))
π©ββοΈ Bier's: prilocaine yes, bupivacaine never, adrenaline never.
A patient dislocates his thumb. Lidocaine ring block is given. What is the main side effect?
- ((Cardiotoxicity::βοΈ NaβΊ-channel block depresses myocardial conduction at toxic plasma levels.))
- ((Methaemoglobinaemia::A prilocaine problem.))
- ((Anaphylaxis::Extremely rare with amides.))
- ((Seizures::Occur in toxicity but cardiotoxicity is the lethal endpoint.))
- ((Digital ischaemia::Caused by adrenaline, not lidocaine.))
A patient injured the tip of their index finger. What is the best anaesthetic for a ring block?
- ((Lidocaine (plain)::βοΈ End-artery territory β adrenaline risks digital necrosis.))
- ((Lidocaine with adrenaline::Contraindicated in fingers, toes, nose, ears, penis.))
- ((Bupivacaine::More cardiotoxic; lidocaine is standard for ring blocks.))
- ((Prilocaine::Usable but lidocaine is first-line.))
- ((Topical EMLA cream::Insufficient depth.))
π©ββοΈ No adrenaline in "Fingers, Toes, Nose, Ears, and the Hose."
Which is the best anaesthesia type for a pilar (trichilemmal) cyst removal in the scalp?
- ((Lidocaine with adrenaline::βοΈ Vasoconstriction gives haemostasis in the vascular scalp and prolongs the block.))
- ((Lidocaine plain::Anaesthetises but leaves a bloody field.))
- ((General anaesthesia::Overkill for a minor excision.))
- ((Bupivacaine with adrenaline::Unnecessarily long and more cardiotoxic.))
- ((Topical anaesthesia::Inadequate for excision.))
A 50 kg patient requires 1% lidocaine + adrenaline for a scalp wound. What is the maximum dose?
- ((35 mL::βοΈ 7 Γ 50 = 350 mg; 1% = 10 mg/mL β 35 mL.))
- ((15 mL::Plain lidocaine max (3 mg/kg).))
- ((50 mL::Exceeds safe maximum.))
- ((25 mL::Arithmetic error.))
- ((70 mL::Twice the safe dose.))
π©ββοΈ Volume (mL) = (weight Γ mg/kg) Γ· concentration (mg/mL).
Which drug is best for induction in a shocked patient?
- ((Ketamine::βοΈ Sympathomimetic β raises BP and HR; preserves airway reflexes.))
- ((Bupivacaine::A local anaesthetic.))
- ((Sodium thiopentone::Vasodilator and myocardial depressant.))
- ((Suxamethonium::A muscle relaxant.))
- ((Propofol::Profound vasodilation β avoid in shock.))
Which induction agent to intubate a hypotensive patient being transported by helicopter?
- ((Ketamine::βοΈ Pre-hospital drug of choice β supports BP, gives analgesia.))
- ((Propofol::Drops BP.))
- ((Vecuronium::A muscle relaxant.))
- ((Sodium thiopentone::Drops BP.))
- ((Midazolam::Sedative; hypotensive as sole induction.))
π©ββοΈ Ketamine is the only induction agent that raises BP.
What general anaesthetic is cardiovascularly stable in hypotensive patients?
- ((Etomidate::βοΈ Haemodynamically neutral β minimal effect on BP or HR.))
- ((Ketamine::Raises BP rather than being "stable".))
- ((Sodium thiopentone::Significant hypotension.))
- ((Propofol::Moderate hypotension.))
- ((Sevoflurane::Dose-dependent vasodilation.))
π©ββοΈ "Stable" β etomidate. "Raises BP" β ketamine. The stem keyword decides.
Which of the following is a depolarising neuromuscular blocker?
- ((Suxamethonium::βοΈ Only depolariser in use; rapid onset, ultra-short duration.))
- ((Vecuronium::Non-depolarising.))
- ((Atracurium::Non-depolarising; Hofmann elimination.))
- ((Rocuronium::Non-depolarising; sugammadex reverses.))
- ((Pancuronium::Non-depolarising.))
π©ββοΈ All "-curoniums" are non-depolarising.
Post-colonoscopy a patient is unresponsive with slow respiratory rate and pinpoint pupils. Which drug reverses the sedation?
- ((Naloxone::βοΈ Classic opioid triad β miosis, bradypnoea, depressed consciousness.))
- ((Flumazenil::Reverses benzodiazepines.))
- ((Neostigmine::Reverses non-depolarising block.))
- ((Atropine::Anticholinergic for bradycardia.))
- ((N-acetylcysteine::Paracetamol antidote.))
What is the mechanism of action of naloxone?
- ((Competitive antagonism at ΞΌ-opioid receptors::βοΈ Displaces opioids; reversible binding.))
- ((Non-competitive antagonism::Same site as opioids β competitive.))
- ((Inverse agonism::Naloxone is a pure antagonist.))
- ((Irreversible receptor blockade::Reversible β hence re-narcotisation risk.))
- ((Enzyme inhibition::Wrong site of action.))
π©ββοΈ Naloxone tΒ½ ~30β60 min is shorter than most opioids β anticipate re-narcotisation.
Which drug reverses non-depolarising neuromuscular blockade?
- ((Neostigmine::βοΈ AChE inhibitor; raises synaptic ACh to outcompete the blocker. Give with glycopyrrolate.))
- ((Dantrolene::For malignant hyperthermia.))
- ((Naloxone::Opioid antagonist.))
- ((Intralipid::For LA toxicity.))
- ((Sugammadex::Specific to roc/vec; neostigmine is the classic exam answer for any non-depolariser.))
Morphine is a full agonist on which receptors?
- ((ΞΌ opioid receptors::βοΈ Mediate analgesia, euphoria, respiratory depression, miosis, βGI motility.))
- ((ΞΊ opioid receptors::Minor activity.))
- ((Ξ΄ opioid receptors::Minor role.))
- ((Ξ± adrenergic receptors::Sympathetic system.))
- ((GABA receptors::Benzodiazepine/barbiturate target.))
Binding to which receptor mediates morphine's respiratory depressant effect?
- ((ΞΌ opioid receptors::βοΈ Brainstem ΞΌ receptors blunt COβ response.))
- ((ΞΊ opioid receptors::Dysphoria and sedation, not respiratory drive.))
- ((Ξ΄ opioid receptors::Minor role.))
- ((Nicotinic::Neuromuscular junction.))
- ((Muscarinic::Cholinergic β wrong family.))
When placing a chest tube, LA reaches the parietal pleura via which nerves?
- ((Intercostal nerves::βοΈ Costal parietal pleura β somatic T1βT11, sharp localised pain.))
- ((Phrenic nerve::Mediastinal/diaphragmatic pleura; pain referred to shoulder (C3βC5).))
- ((Vagus nerve::Visceral pleura β no pain.))
- ((Long thoracic nerve::Motor to serratus anterior.))
- ((Sympathetic chain::Autonomic, not somatic.))
π©ββοΈ Costal β intercostals. Diaphragmatic/mediastinal β phrenic (shoulder tip). Visceral β vagus (no pain).
A patient with bone metastases from breast cancer presents with pain. What is the management?
- ((Radiotherapy::βοΈ Gold standard for painful bone metastases.))
- ((Chemotherapy::Treats disease but not first-line for focal bone pain.))
- ((Bisphosphonates alone::Adjunct only.))
- ((Surgical fixation::For actual/impending pathological fracture.))
- ((Increasing oral morphine only::Symptom control without addressing cause.))
A patient with metastatic renal cancer has a painful lesion in the left humerus. What is the management?
- ((Radiotherapy::βοΈ Targeted relief for painful bone metastases.))
- ((Prophylactic intramedullary nailing::For high fracture risk (Mirels), not pain alone.))
- ((Amputation::Disproportionate.))
- ((NSAIDs alone::Inadequate.))
- ((Observation and analgesia::Radiotherapy more effective.))
A man with bronchogenic carcinoma presents with early morning headache, nausea, and visual blurring. What is the initial management?
- ((Dexamethasone::βοΈ Reduces vasogenic oedema around brain metastases β fastest relief.))
- ((Urgent CT head::Needed but dexamethasone is the immediate therapeutic step.))
- ((Mannitol::For acute herniation, not subacute oedema.))
- ((Whole brain radiotherapy::Definitive but not initial.))
- ((Surgical decompression::Medical management first.))
A patient with known breast carcinoma presents with headache and vomiting. What is the initial management?
- ((Dexamethasone::βοΈ Reduces cerebral oedema from brain metastases.))
- ((Antiemetics alone::Treats symptom, not cause.))
- ((Lumbar puncture::Contraindicated if raised ICP β coning risk.))
- ((Urgent neurosurgical referral::May follow; not the immediate step.))
- ((Furosemide::Not first-line for tumour oedema.))
π©ββοΈ Cancer + early morning headache + vomiting + visual change = raised ICP from brain mets β dexamethasone. Never LP.
Revision summary
β‘ Induction: propofol (βBP), thiopentone (avoid porphyria), ketamine (βBP β shock), etomidate (neutral β adrenal suppression).
β‘ Suxamethonium β only depolariser; RSI; hyperkalaemia, MH trigger, sux apnoea.
β‘ Non-depolarisers ("-curoniums") β neostigmine + glycopyrrolate; sugammadex for roc/vec.
β‘ Lidocaine: 3 mg/kg plain, 7 mg/kg with adrenaline. 1% = 10 mg/mL.
β‘ Bupivacaine β most cardiotoxic; never in Bier's. Prilocaine β least toxic; IVRA agent; methaemoglobinaemia risk.
β‘ No adrenaline in fingers, toes, nose, ears, penis.
β‘ LA toxicity: lipsβearsβeyesβseizuresβarrest. Treat with 20% Intralipid.
β‘ Spinal = single shot, subarachnoid, below L2. Epidural = catheter, extradural; PDPH risk.
β‘ WHO ladder: non-opioid β weak opioid β strong opioid Β± adjuvants.
β‘ Opioid triad (miosis + bradypnoea + βGCS) β naloxone (short tΒ½ β re-narcotisation).
β‘ NSAIDs: avoid in renal failure, GI bleeding, severe HF, aspirin-sensitive asthma.
β‘ MH: RyR1; triggered by volatiles + sux; treat dantrolene.
β‘ Cancer + raised ICP β dexamethasone; painful bone mets β radiotherapy.